CJC-1295 (No DAC) + Ipamorelin Blend – Research Peptide
This combination blend pairs CJC-1295 without DAC (Modified GRF 1-29) with Ipamorelin — two complementary growth hormone secretagogues that act through distinct but synergistic receptor pathways to stimulate pulsatile GH release in research models.
Research Context
CJC-1295 activates GHRH receptors (GHRHR) via Gs-cAMP-PKA signaling, while Ipamorelin activates the ghrelin receptor (GHSR-1a) via PLC-dependent calcium mobilization. Combined use allows researchers to investigate parallel endocrine signaling pathways and amplified IGF-axis modulation in cellular and animal models.
Properties
- CJC-1295 (no DAC): 5mg per vial
- Ipamorelin: 5mg per vial
- Form: Lyophilized powder
- Purity: ≥98% each component (HPLC verified)
Storage & Handling
Store each vial at -20°C. Reconstitute with sterile bacteriostatic water separately or per protocol. Refrigerate at 2–8°C after reconstitution.
Disclaimer: This product is strictly intended for in vitro laboratory research purposes only. Not for human or veterinary use.
